323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA
Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Shareholder votes
Reports First Quarter 2025 Financial Results and Provides Corporate Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Annual Report to Security Holders
Earnings Release
Material disclosure
Q2
Q1
FY 2024
Q3
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
SC TO-I
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Correspondence